Sofi Francesco, Cesari Francesca, Fedi Sandra, Abbate Rosanna, Gensini Gian Franco
Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Italy.
Clin Lab. 2004;50(11-12):647-52.
Protein Z is a vitamin K-dependent plasma protein described in its human form in 1984. The amino acid sequence of protein Z shows wide homology with many coagulation factors, such as VII, IX, X, and protein C. However, in contrast to other vitamin K-dependent coagulation factors, protein Z is not a serine protease because of the lack of the active centre in its amino acid sequence. The physiological function of protein Z has been uncertain for many years. In vitro and in vivo studies recently suggested that protein Z plays an important role in inhibiting coagulation, as it serves as cofactor for the inactivation of activated factor X by forming a complex with the plasma protein Z-dependent protease inhibitor. The role of alterations of the protein Z levels has been evaluated in different disease states, with conflicting findings. Most of these studies were performed on ischemic vascular diseases. Recently, the possible role of protein Z deficiency in the occurrence of cardiovascular diseases has been evaluated.
蛋白Z是一种维生素K依赖的血浆蛋白,于1984年以其人类形式被描述。蛋白Z的氨基酸序列与许多凝血因子,如因子VII、IX、X和蛋白C,具有广泛的同源性。然而,与其他维生素K依赖的凝血因子不同,蛋白Z不是丝氨酸蛋白酶,因为其氨基酸序列中缺乏活性中心。多年来,蛋白Z的生理功能一直不确定。最近的体外和体内研究表明,蛋白Z在抑制凝血中起重要作用,因为它通过与血浆蛋白Z依赖的蛋白酶抑制剂形成复合物,作为灭活活化因子X的辅因子。在不同疾病状态下评估了蛋白Z水平改变的作用,但结果相互矛盾。这些研究大多是针对缺血性血管疾病进行的。最近,评估了蛋白Z缺乏在心血管疾病发生中的可能作用。